Skip to main content
. Author manuscript; available in PMC: 2011 Jun 14.
Published in final edited form as: Breast Cancer Res Treat. 2007 Aug 3;110(1):143–152. doi: 10.1007/s10549-007-9686-5

Table 4.

Demographic, psychosocial, surgical, and blood work variables by cognitive performance status (Stages 1–3 pts only)

Lower than expected cognitive performance (N = 24)a Normal performance (N = 86) p-value
Age 55.8 (9.4) 53.8 (7.9) 0.28
Education 15.8 (3.2) 15.1 (2.3) 0.26
CESD Depression 10.5 (8.5) 9.1 (7.5) 0.44
STAI Anxiety 35.2 (12.5) 31.7 (11.4) 0.20
FAT Fatigue 2.3 (1.7) 2.4 (1.7) 0.87
MASQ Total 87.9 (26.5) 84.5 (21) 0.50
Menstrual status
 Regular periods 4 (17%) 24 (29%) 0.40
 Irregular periods 2 (9%) 5 (6%)
 Stopped/pregnancy 0 (0%) 0 (0%)
 Begun to stop 3 (13%) 4 (5%)
 Stopped permanently 14 (61%) 49 (60%)
 Regular alcohol use 8 (33%) 46 (56%) 0.084
Smoking
 Yes 0 (0%) 9 (13%) 0.16
 Previous smoker 13 (76%) 36 (52%)
 Never smoked 4 (24%) 24 (35%)
Surgerya
 Lumpectomy 8 (33%) 32 (37%) 0.13
 Lumpectomy + re-excision 9 (38%) 16 (19%)
 Mastectomy 2 (8%) 24 (28%)
 Mastectomy + reconstruction 5 (21%) 12 (14%)
 None/other 0 (0%) 2 (2%)
 Hours of exposure to general anesthesia 3.9 (2.7) 3.4 (2.7) 0.55
Taking hormones 1 (4%) 4 (5%) 0.66
Bloodwork
 White blood count 7.8 (3) 7.3 (2.2) 0.40
 Red Blood Count 4.4 (0.4) 4.3 (0.4) 0.44
 Hemoglobin 13.2 (1.3) 13.3 (1.4) 0.80
 Platelets 289.8 (67.4) 307.8 (73.2) 0.28
 B12 667.8 (316.5) 705 (334.5) 0.63
 Folate 17.3 (5.5) 20.1 (6.5) 0.066
 Thyroid Stimulating Hormone 1.5 (0.9) 1.9 (1) 0.082
a

Prior to assessment